Y Lecrubier

Summary

Country: France

Publications

  1. ncbi Is amisulpride an 'atypical' atypical antipsychotic agent?
    Y Lecrubier
    INSERM Unité 302, H pital La Salpêtrière, Paris, France
    Int Clin Psychopharmacol 15:S21-6. 2000
  2. ncbi Auditory hallucinations in pre-pubertal children. A one-year follow-up, preliminary findings
    Florence L Askenazy
    Service Universitaire de Psychiatrie de l Enfant et de l Adolescent Fondation LENVAL, 57 avenue de la Californie, 06200 Nice, France
    Eur Child Adolesc Psychiatry 16:411-5. 2007
  3. ncbi Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder
    Yves Lecrubier
    INSERM, Hopital de la Salpetriere, Paris, France
    Eur Arch Psychiatry Clin Neurosci 258:171-8. 2008
  4. ncbi Recognizing and effectively treating depression
    Yves Lecrubier
    French National Institute of Health and Medical Research, Hopital Pitie Salpetriere, Paris, France
    CNS Spectr 13:5-9. 2008
  5. ncbi Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies
    Yves Lecrubier
    Hopital La Salpetriere, INSERM, Paris, France
    J Clin Psychiatry 68:36-41. 2007
  6. ncbi The Ham D(6) is more homogenous and as sensitive as the Ham D(17)
    Y Lecrubier
    INSERM U 302, Bâtiment de la Force Pavillon Clérambault, Hopital de la Salpetriere, 47 Boulevard de l Hopital, 75013 Paris, France
    Eur Psychiatry 22:252-5. 2007
  7. ncbi Posttraumatic stress disorder in primary care: a hidden diagnosis
    Yves Lecrubier
    Hopital La Salpetriere, INSERM, Paris, France
    J Clin Psychiatry 65:49-54. 2004
  8. ncbi False beliefs: the current treatment of patients with depression
    Yves Lecrubier
    Unité INSERM 302, Hopital de la Salpetriere, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Curr Psychiatry Rep 5:419-22. 2003
  9. ncbi Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional survey
    Yves Lecrubier
    Unité INSERM 302, Pavillon Clerambault, Hopital Pitie Salpetriere, 47 Boulevard de l Hopital, F 75013 Paris, France
    Eur Psychiatry 22:371-9. 2007
  10. doi Refinement of diagnosis and disease classification in psychiatry
    Yves Lecrubier
    INSERM U 302, Hopital de la Pitie Salpetriere, Paris, France
    Eur Arch Psychiatry Clin Neurosci 258:6-11. 2008

Detail Information

Publications28

  1. ncbi Is amisulpride an 'atypical' atypical antipsychotic agent?
    Y Lecrubier
    INSERM Unité 302, H pital La Salpêtrière, Paris, France
    Int Clin Psychopharmacol 15:S21-6. 2000
    ..Amisulpride is therefore indeed an 'atypical atypical'--a flexible antipsychotic the use of which can be tailored to the changing needs of the patient. It is thus a suitable first-line choice for the treatment of schizophrenia...
  2. ncbi Auditory hallucinations in pre-pubertal children. A one-year follow-up, preliminary findings
    Florence L Askenazy
    Service Universitaire de Psychiatrie de l Enfant et de l Adolescent Fondation LENVAL, 57 avenue de la Californie, 06200 Nice, France
    Eur Child Adolesc Psychiatry 16:411-5. 2007
    ..The aims of this study were to describe the phenomenology of auditory hallucinations in children, to establish links with DSM IV diagnoses and to explore development of the hallucinations over a 12-month period...
  3. ncbi Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder
    Yves Lecrubier
    INSERM, Hopital de la Salpetriere, Paris, France
    Eur Arch Psychiatry Clin Neurosci 258:171-8. 2008
    ..Anxiety symptoms are very common in patients with MDD or GAD, and the symptomatic pattern is similar. In both disorders, the symptomatic pattern of residual symptoms is similar to the pattern of symptoms before treatment...
  4. ncbi Recognizing and effectively treating depression
    Yves Lecrubier
    French National Institute of Health and Medical Research, Hopital Pitie Salpetriere, Paris, France
    CNS Spectr 13:5-9. 2008
    ....
  5. ncbi Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies
    Yves Lecrubier
    Hopital La Salpetriere, INSERM, Paris, France
    J Clin Psychiatry 68:36-41. 2007
    ..The willingness to prescribe antidepressants and anxiolytic agents is influenced, in part, by diagnosis, patient age and gender, comorbidity (and severity), and the number of spontaneous psychological complaints...
  6. ncbi The Ham D(6) is more homogenous and as sensitive as the Ham D(17)
    Y Lecrubier
    INSERM U 302, Bâtiment de la Force Pavillon Clérambault, Hopital de la Salpetriere, 47 Boulevard de l Hopital, 75013 Paris, France
    Eur Psychiatry 22:252-5. 2007
    ..t. comparing an hypericum extract (W55570) to placebo in depressed patients we explored whether the Ham D(6) was unidimentional and in case of a positive answer whether the total score was as sensitive as the total score of the Ham D(17)...
  7. ncbi Posttraumatic stress disorder in primary care: a hidden diagnosis
    Yves Lecrubier
    Hopital La Salpetriere, INSERM, Paris, France
    J Clin Psychiatry 65:49-54. 2004
    ....
  8. ncbi False beliefs: the current treatment of patients with depression
    Yves Lecrubier
    Unité INSERM 302, Hopital de la Salpetriere, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Curr Psychiatry Rep 5:419-22. 2003
  9. ncbi Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional survey
    Yves Lecrubier
    Unité INSERM 302, Pavillon Clerambault, Hopital Pitie Salpetriere, 47 Boulevard de l Hopital, F 75013 Paris, France
    Eur Psychiatry 22:371-9. 2007
    ..To describe physicians' observations and perceptions of patients with schizophrenia and to obtain information about antipsychotic prescribing practices...
  10. doi Refinement of diagnosis and disease classification in psychiatry
    Yves Lecrubier
    INSERM U 302, Hopital de la Pitie Salpetriere, Paris, France
    Eur Arch Psychiatry Clin Neurosci 258:6-11. 2008
    ....
  11. ncbi Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial
    Y Lecrubier
    Unité Institut National de la Santé et de la Recherche Médicale 302, Hopital Pitie Salpetriere, Paris, France
    Am J Psychiatry 159:1361-6. 2002
    ..In a double-blind, randomized, placebo-controlled trial with 375 patients the authors investigated the antidepressant efficacy and safety of 300 mg t.i.d. of hydroalcoholic Hypericum perforatum extract WS 5570...
  12. ncbi The influence of comorbidity on the prevalence of suicidal behaviour
    Y Lecrubier
    Hopital de la Salpetriere, Pavillon Clerambault, 47, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Eur Psychiatry 16:395-9. 2001
    ..The number of associated disorders linearly increases the probability of attempting suicide and is the only significant predictor for lethality. A proper treatment of mental disorders could substantially lower suicidality...
  13. ncbi Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia
    Y Lecrubier
    INSERM Unité 302, Hopital de la Salpetriere, Paris, France
    Neuropsychobiology 44:41-6. 2001
    ..The French experience emphasizes the central role of amisulpride as a first-line treatment of schizophrenia...
  14. ncbi The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial
    Y Lecrubier
    Pitié Salpétrière U 302 Hospital, Paris Cedex, France
    Acta Psychiatr Scand 114:319-27. 2006
    ..The aim of the study was to evaluate the efficacy of olanzapine (5 and 20 mg/day) over a 6-month period in chronic schizophrenic patients experiencing predominantly negative symptoms...
  15. ncbi The relevance of recurrent brief depression in primary care. A report from the WHO project on Psychological Problems in General Health Care conducted in 14 countries
    E Weiller
    INSERM U302, , Paris, France
    Eur Arch Psychiatry Clin Neurosci 244:182-9. 1994
    ..Our results confirm the relevance of the concept of RBD in primary care, and the need to further explore the pertinence of the restrictive recurrence criterion proposed by Angst...
  16. ncbi Prescribing patterns for depression and anxiety worldwide
    Y Lecrubier
    , INSERM, , Paris, France
    J Clin Psychiatry 62:31-6; discussion 37-8. 2001
    ..Patterns observed in Western societies are compared with those seen in the rest of the world and are discussed with a view to educational needs for primary care physicians...
  17. ncbi The burden of depression and anxiety in general medicine
    Y Lecrubier
    INSERM, , , Paris, France
    J Clin Psychiatry 62:4-9; discussion 10-1. 2001
    ..Recognition and treatment, however, relieve the burden imposed by untreated depression on the individual, society, and health services...
  18. ncbi Prevalence of recurrent brief depression in primary care
    E Weiller
    INSERM U302, , Paris, France
    Eur Arch Psychiatry Clin Neurosci 244:174-81. 1994
    ..Our results are in favor of the existence of RBD as a separate and original nosological entity...
  19. ncbi Physical components of depression and psychomotor retardation
    Yves Lecrubier
    Hopital La Salpetriere, INSERM, Paris, France
    J Clin Psychiatry 67:23-6. 2006
    ..In addition, data have indicated significantly improved psychomotor retardation in patients with depression after 3 months of treatment...
  20. ncbi Quality of life in patients with bipolar I depression: data from 920 patients
    Lakshmi N Yatham
    The University of British Columbia, Vancouver, BC, Canada
    Bipolar Disord 6:379-85. 2004
    ..To determine the impact of acute depression on quality of life (QOL) in patients with bipolar I disorder and to compare these results with published data on QOL in patients with unipolar depression...
  21. ncbi Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study
    Daniel Sechter
    Department of Psychiatry, Saint Jacques Hospital, 2 Place Saint Jacques, 25030 Besancon Cedex, France
    Neuropsychopharmacology 27:1071-81. 2002
    ..Both treatments were well tolerated and had a similar low incidence of extrapyramidal symptoms; however, amisulpride was associated with less weight gain and endocrine/sexual symptoms...
  22. ncbi Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
    Eur Psychiatry 23:169-77. 2008
    ..An online survey of European psychiatrists assessed awareness of the metabolic syndrome and its influence on the management of bipolar disorder...
  23. ncbi Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study
    Daniel Souery
    Department of Psychiatry, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium
    J Clin Psychiatry 68:1062-70. 2007
    ....
  24. ncbi Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses
    Judit Balazs
    Department of Psychiatry and Psychotherapy, Semmelweis University, Balassa str 6, 1083 Budapest, Hungary
    J Affect Disord 76:113-9. 2003
    ..The purpose of this study was to investigate the prevalence and comorbidity of affective disorders, especially current major depressive episode and bipolar disorder among suicide attempters in Hungary...
  25. ncbi Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxiety
    David J Nutt
    University of Bristol, Bristol, United Kingdom
    J Clin Psychiatry 68:42-8. 2007
    ..In addition, how this large and unique dataset may be utilized for maximum benefit to patients is outlined...
  26. ncbi Anxiety and impulsivity levels identify relevant subtypes in adolescents with at-risk behavior
    Florence L Askenazy
    Service universitaire de psychiatrie de l enfant et de l adolescent, Fondation Lenval, 57, avenue de la Californie, 06200 Nice, France
    J Affect Disord 74:219-27. 2003
    ..We therefore classified them into sub-groups according to these two major dimensions. The study examined the relevance of these groups by describing their major diagnoses and behavioral characteristics...
  27. ncbi Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety
    James C Ballenger
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    J Clin Psychiatry 65:55-62. 2004
    ....
  28. ncbi Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment
    David J Nutt
    Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol, UK
    J Clin Psychiatry 67:46-9. 2006
    ..In addition, the faculty discussed the importance of patient psychoeducation and self-management as well as the ways in which disease models of depression affect treatment...